SecBot SecBot
SC 13G/A ·Filed Nov 12, 2026

ELAN

Elanco Animal Health Inc
NEUTRAL
Impact 2/10
Horizonimmediate Processed4d 11h ago SEC0001193125-26-458582
Passive stake amendment
Actionable Insight • Neutral

The reduction is small and typical for a passive manager; no signal of negative conviction. Monitor future 13G filings for further trimming, but this filing alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$26.78
T+0 close · Nov 12, 2026 · via day close
Latest settled
−1.38%
T+1 · $26.41
Vs SPY
+0.53%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $26.78entry
  2. T+1 · 21h ago −1.38%α +0.53% · $26.41
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dodge & Cox filed an amended Schedule 13G disclosing a 12.3% passive stake in Elanco Animal Health as of September 30, 2026, down from 13.3% in the prior filing. The reduction is modest and consistent with routine portfolio rebalancing by a passive investment manager.

Key Financial Metrics

Stake
12.3%
Investor
Dodge & Cox
Investor Type
mutual fund

Key Facts

  • Dodge & Cox reported beneficial ownership of 61,430,997 shares of Elanco Animal Health common stock as of September 30, 2026
  • The stake represents 12.3% of shares outstanding, down from 13.3% in the prior filing (May 2026)
  • Dodge & Cox Stock Fund holds 38,409,300 shares or 7.7% of the class
  • The filing is a passive Schedule 13G/A under Rule 13d-1(b)

Financial Impact

Stake decreased by approximately 1.0 percentage point (from 13.3% to 12.3%)

ownership_percentage

Risk Factors

  • Continued gradual selling by Dodge & Cox could pressure the stock over time
  • No indication of activist intent; passive filing status confirmed

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001193125-26-458582
Document: 0001193125-26-458582-index.html0001193125-26-458582
Document: 0001193125-26-458582.txt0001193125-26-458582

Track record

19 reports on ELAN

Performance horizon

5 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +15.03% at T+5 after the May 19, 2026 report. 9 of 10 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $26.68 Now $26.41 −1.01% settles Feb 12
  2. Nov 12, 20264d ago SC 13G/A Neutral 2/10 Viewing Entry $26.78 Now $26.41 −1.38% settles Feb 11
  3. Nov 6, 202610d ago 8-K Bullish 6/10 Entry $25.74 Now $26.41 +2.60% settles Feb 4
  4. Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $23.68 Now $26.41 +11.53% settles Feb 3
  5. Nov 3, 202613d ago 3 Neutral 1/10 Entry $25.31 Now $26.41 +4.35% settles Feb 2
  6. Oct 14, 20264w ago Institutional Cluster Bullish 4/10 Entry $23.54 Now $26.41 +12.19% settles Jan 12
  7. Sep 11, 20269w ago Press Release Neutral 1/10 Entry $23.17 Now $26.41 +13.98% settles Dec 7
  8. Aug 21, 202612w ago Insider Cluster Bullish 6/10 Entry $24.42 Now $26.41 +8.15% settles Nov 17
  9. Aug 21, 202612w ago Insider Cluster Bullish 4/10 Entry $24.42 Now $26.41 +8.15% settles Nov 17
  10. Aug 18, 202612w ago Insider Cluster Bullish 4/10 Entry $24.50 to $26.50 Now $26.41 +7.80% ▲ +8.16% +9.72% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens in 5h 29m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026